Yikilmaz, T. N., Dirim, A., Ayva, E. S., Ozdemir, H., & Ozkardes, H. (2016). Clinical Use of Tumor Markers for the Detection and Prognosis of Bladder Carcinoma: A Comparison of CD44, Cytokeratin 20 and Survivin. Urology Journal, 13(3), 2677–2683. https://doi.org/10.22037/uj.v13i3.3294